The CMT Research Foundation (CMTRF) is a non-profit organization dedicated to delivering treatments and cures for Charcot-Marie-Tooth disease (CMT). It is a patient-led entity that funds research, supports drug development, and raises awareness about CMT. The foundation collaborates with researchers, clinicians, and pharmaceutical companies to accelerate clinical trials and therapeutic advancements for CMT patients.

The CMT Research Foundation

The CMT Research Foundation has one single focus: deliver treatments and cures for CMT.  Led by two experts in Charcot-Marie-Tooth (CMT) who have over 20 years of collective experience working with CMT researchers, the CMTRF supports the most promising and effective research aimed at drug delivery. By developing strategic partnerships with researchers, pharmaceutical and biotechnology professionals, as well as a national network of CMT patients, the CMT Research Foundation is instrumental in achieving successful outcomes in CMT research for treatment and cure delivery.CMT is a progressive genetic nerve disease and can lead to severe disability or even death. CMT has over 90 known genetic causes and can be passed down in multiple generations. Onset can be at birth or later in life and is characterized by loss of muscles and sensation in the feet, hands, legs and arms. Nearly three million people of every age, race and ethnicity are living with CMT. Currently there is no cure for CMT; and there are not any effective treatments. CMT is a genetic disease with a high unmet need, giving pharmaceutical companies incentives to deliver clinical trials and eventually, treatments and cures for CMT. With your help, the CMT Research Foundation will not stop until cures for all types of CMT have been delivered.

Metric
Company Name	The CMT Research Foundation
Symbol
MSH ID	ORG:CMTRF
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare & Health Services
Country	US
Stage
Employee Count	18
Website	cmtrf.org
LinkedIn	cmt-research-foundation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ORG:CMTRF

The CMT Research Foundation

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue